Alcon, Betaxolol,
ALO 1401 02,
ALO-1401-02,
ALO140102,
Betaxolol,
Betaxolol Alcon,
Betaxolol Hydrochloride,
Betoptic,
Betoptima,
Hydrochloride, Betaxolol,
Kerlon,
Kerlone,
Oxodal,
SL 75212,
SL-75212,
SL75212,
Betaxolol hydrochloride,
63659-19-8,
Betaxolol HCL,
Betoptima,
Kerlone,
Lokren,
Kerlon,
Betaxolo Hydrochloride,
Betaxolol (hydrochloride),
Betoptic S,
alo 1401-02,
Betaxolol hydrochloride (Betoptic),
EINECS 264-384-3,
MFCD00242959,
MLS000863279,
SL 75 212-10,
CPD000058420,
SMR000058420,
SL 75.212-10,
(+-)-1-(p-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-(isopropylamino)-2-propanol hydrochloride,
1-(4-(2-(Cyclopropylmethoxy)ethyl)phenoxy)-3-isopropylaminopropan-2-ol hydrochloride,
1-(isopropylamino)-3-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]propan-2-ol hydrochloride,
SL-75212,
Q-200714,
1-(Isopropylamino)-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol hydrochloride,
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride,
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-, hydrochloride, (+-)-,
CHEBI:643228,
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol hydrochloride,
SR-01000000108,
SL-75212-10,
Kerlong,
Betaxolol hydrochloride [USAN],
Betoptic (TN),
Prestwick_779,
Kerlone (TN),
Betaxolol hydrochloride [USAN:USP:JAN],
Betaxolol(hydrochloride),
Opera_ID_878,
Lokren ,Kerlone ;Betoptic,
AC1Q3DQ4,
CHEMBL1691,
SCHEMBL42794,
MLS000028464,
MLS000758269,
MLS001148209,
MLS001424199,
MLS002222261,
betaxolol-hydrochloride-betoptic,
AC1L331T,
SL 75212 HCl,
CTK8F0839,
HY-B0381A,
MCI-144,
CHDPSNLJFOQTRK-UHFFFAOYSA-N,
HMS1569M05,
Pharmakon1600-01505512,
BCP02967,
Tox21_500193,
Betaxolol hydrochloride (JP17/USP),
BG0105,
NSC760048,
AKOS015843993,
AC-1412,
API0001701,
BCP9000394,
CCG-101057,
CCG-213473,
CS-2453,
LP00193,
NC00307,
NSC-760048,
Betaxolol hydrochloride, >98% (HPLC),
KS-00001F73,
NCGC00093669-01,
NCGC00093669-02,
NCGC00260878-01,
AK546473,
AK608094,
AN-14973,
AS-18082,
BC227944,
SAM001247084,
BCP0726000249,
AB2000314,
LS-122006,
TC-071428,
B4474,
EU-0100193,
FT-0645228,
S1827,
SW196917-4,
W0012,
B 5683,
D00598,
659X198,
A803574,
I06-1154,
SR-01000000108-2,
SR-01000000108-4,
SR-01000000108-9,
Betaxolol hydrochloride, European Pharmacopoeia (EP) Reference Standard,
Betaxolol hydrochloride, United States Pharmacopeia (USP) Reference Standard,
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(isopropylamino)propan-2-ol hydrochloride,
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)-2-propanol hydrochloride,
1-[4-[2-(Cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanol hydrochloride,
1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-isopropylamino-2-propanolhydrochloride,
Betaxolol for peak identification, European Pharmacopoeia (EP) Reference Standard,
(2S)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol;hydrochloride,
(2S)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-olhydrochloride,
2-Propanol, 1-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)-3-((1-methylethyl)amino)-,hydrochloride,
72424-72-7,
Betoptic,
betaxolol,
BETOPTIC PILO,
Betaxololhydrochloride,
KERLEDEX,
LEVOBETAXOLOL HYDROCHLORIDE,
UNII-6X97D2XT0O,
C18H30ClNO3,
C18H29NO3.ClH,
C18H29NO3.HCl,
6X97D2XT0O,
C18-H29-N-O3.Cl-H,
AR-1H6839,
CID107952,
ACN-040049,
CS-O-11610,
ALO-1401-02,
SL 75212,
116209-55-3,
7511-72-0,